Asia-Pacific

AstraZeneca and China International Capital to launch $1 bln China biotech venture fund: Bloomberg

U.S. drugmaker AstraZeneca and China International Capital Corp are teaming up to launch a $1 billion China-focused biotech venture fund, reported Bloomberg. The news outlet added that AstraZeneca will not be a majority investor, according to CEO Pascal Soriot.

Southeast Asia. Which country has the most unicorns and the largest population?

Indonesia leads the way in number of current unicorns, followed by Singapore, which is closing the gap with some almost-unicorns

China and Italy post strong IRR results for active VC funds

However, the U.S. ranks atop with 14.4 percent historical return that includes data from active and liquidated VC funds, based on 350 active funds

Why Australia’s Hostplus is piling into venture

Neil Stanford, head of PE at the A$45bn superannuation fund, discusses the LP's push into Aussie VC and its aversion to large domestic buyouts.

Monk's Hill Ventures seeks second fund as Southeast Asian activity surges

China’s tech revolution creates diversification headache for LPs

A growing number of Chinese businesses are being marketed as TMT-based, an industry conference in Hong Kong has heard.

In a more subdued China, venture funding for agtech soars

Second Vision Fund seen as likely

Northern Light Venture Capital raises nearly $450 mln for fifth fund